Search Results - "Schneibel, Erik"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Predictors and clinical impact of pre-existing and acquired thrombocytopenia following transcatheter aortic valve replacement by Flaherty, Michael P., Mohsen, Amr, Moore, Joseph B., Bartoli, Carlo R., Schneibel, Erik, Rawasia, Wasiq, Williams, Matthew L., Grubb, Kendra J., Hirsch, Glenn A.

    “…Background Data are limited regarding transcatheter aortic valve replacement (TAVR)‐related thrombocytopenia (TP). We sought to thoroughly characterize the…”
    Get full text
    Journal Article
  2. 2

    Myocardial Infarction Secondary to Left Internal Mammary Artery Graft Occlusion After Left Subclavian Bypass by Rizzi, Scott, Schneibel, Erik, Park, Ki

    Published in JACC. Case reports (01-08-2019)
    “…Cardiogenic shock is a severe, often fatal presentation of acute myocardial infarction. This report presents an unusual case of ST-segment elevation……”
    Get full text
    Journal Article
  3. 3
  4. 4

    LEFT VENTRICULAR ASSIST DEVICE OUTFLOW TRACT THROMBUS FOLLOWING A SUCCESSFUL SLEEVE GASTROSTOMY by Njapo, Steve Noutong, Schneibel, Erik

    “…Conclusions: Multiple factors should be considered when managing LVAD pump thrombosis including the patient's clinical response to inotropes, patient…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents: A Meta-Analysis of Randomized Trials by Mahmoud, Ahmed N, Barakat, Amr F, Elgendy, Akram Y, Schneibel, Erik, Mentias, Amgad, Abuzaid, Ahmed, Elgendy, Islam Y

    Published in Circulation. Cardiovascular interventions (01-05-2017)
    “…Data regarding the long-term efficacy and safety of everolimus-eluting bioresorbable vascular scaffolds (BVS) compared with everolimus-eluting stents are…”
    Get full text
    Journal Article
  7. 7
  8. 8